Literature DB >> 9646879

Plasma corticotropin-releasing factor in depressive disorders.

R Catalán1, J M Gallart, J M Castellanos, R Galard.   

Abstract

BACKGROUND: The aim of this work was to investigate alterations of plasma corticotropin-releasing factor (CRF) levels in depressive states. We have also measured plasma cortisol and corticotropin (ACTH) concentrations and examined their correlation with the peripheral CRF values.
METHODS: Thirty-six outpatients from the psychiatric department of a Barcelona hospital who were diagnosed as having major depressive disorder (n = 26) and dysthymic depressive disorder (n = 10) were studied. Among the major depressed patients, 10 suffered from severe depressive disorder and 16 from mild or moderate depressive disorder. The comparison group consisted of 17 healthy volunteers. Cortisol, ACTH, and CRF concentrations were determined by iodine-125 radioimmunoassay; CRF measurements were performed on C18 extracted samples.
RESULTS: CRF and cortisol plasma concentrations were significantly higher in major depression and dysthymia than in the comparison group. The major depressed patients did not show significantly different CRF and cortisol levels than the dysthymic. Severe major depressive disorder exhibited significantly higher CRF plasma levels than the mild or moderate episodes. Plasma cortisol and CRF concentrations correlated significantly.
CONCLUSIONS: The results obtained indicate that plasma CRF values are altered in depressive disorders and suggest that these determinations could be important for understanding the pathophysiology in affective illness.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9646879     DOI: 10.1016/s0006-3223(97)00539-8

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  16 in total

Review 1.  Endogenous digitalis-like Na+, K+-ATPase inhibitors, and brain function.

Authors:  D Lichtstein; H Rosen
Journal:  Neurochem Res       Date:  2001-09       Impact factor: 3.996

2.  Are prenatal psychological or physical stressors associated with suboptimal outcomes in neonates born to adolescent mothers?

Authors:  Kate Keenan; Rebecca Sheffield; Debra Boeldt
Journal:  Early Hum Dev       Date:  2007-02-20       Impact factor: 2.079

3.  Synthesis, F-18 radiolabeling, and microPET evaluation of 3-(2,4-dichlorophenyl)-N-alkyl-N-fluoroalkyl-2,5-dimethylpyrazolo[1,5-a]pyrimidin-7-amines as ligands of the corticotropin-releasing factor type-1 (CRF1) receptor.

Authors:  Jeffrey S Stehouwer; Matthew S Birnbaum; Ronald J Voll; Michael J Owens; Susan J Plott; Chase H Bourke; Michael A Wassef; Clinton D Kilts; Mark M Goodman
Journal:  Bioorg Med Chem       Date:  2015-06-19       Impact factor: 3.641

4.  Shunt related changes in somatostatin, neuropeptide Y, and corticotropin releasing factor concentrations in patients with normal pressure hydrocephalus.

Authors:  M A Poca; M Mataró; J Sahuquillo; R Catalán; J Ibañez; R Galard
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-03       Impact factor: 10.154

5.  Histories of major depression and premenstrual dysphoric disorder: Evidence for phenotypic differences.

Authors:  Rebecca R Klatzkin; Monica E Lindgren; Catherine A Forneris; Susan S Girdler
Journal:  Biol Psychol       Date:  2010-02-04       Impact factor: 3.251

Review 6.  Synaptic physiology of central CRH system.

Authors:  Joel P Gallagher; Luis F Orozco-Cabal; Jie Liu; Patricia Shinnick-Gallagher
Journal:  Eur J Pharmacol       Date:  2008-02-01       Impact factor: 4.432

Review 7.  The long-term impact of early life pain on adult responses to anxiety and stress: Historical perspectives and empirical evidence.

Authors:  Nicole C Victoria; Anne Z Murphy
Journal:  Exp Neurol       Date:  2015-07-22       Impact factor: 5.330

8.  Crossroads of corticotropin releasing hormone, corticosteroids and monoamines. About a biological interface between stress and depression.

Authors:  H. M. Van Praag
Journal:  Neurotox Res       Date:  2002 Aug-Sep       Impact factor: 3.911

9.  5HT1A-mediated stimulation of cortisol release in major depression: use of non-invasive cortisol measurements to predict clinical response.

Authors:  George I Papakostas; Sarah E Chuzi; Jessica L Sousa; Maurizio Fava
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-07-30       Impact factor: 5.270

10.  Synthesis, binding affinity, radiolabeling, and microPET evaluation of 4-(2-substituted-4-substituted)-8-(dialkylamino)-6-methyl-1-substituted-3,4-dihydropyrido[2,3-b]pyrazin-2(1H)-ones as ligands for brain corticotropin-releasing factor type-1 (CRF1) receptors.

Authors:  Jeffrey S Stehouwer; Chase H Bourke; Michael J Owens; Ronald J Voll; Clinton D Kilts; Mark M Goodman
Journal:  Bioorg Med Chem Lett       Date:  2015-10-08       Impact factor: 2.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.